BW Gestao de Investimentos Ltda. Trims Stock Holdings in CVS Health Corporation $CVS

Key Points

• BW Gestao de Investimentos Ltda. reduced its holdings in CVS Health by 16.7%, selling 30,000 shares, and now owns 150,000 shares valued at approximately $10.16 million.
• CVS Health reported better-than-expected earnings with $1.81 EPS and revenue of $98.92 billion for the last quarter, exceeding analysts' estimates.
• The stock recently experienced a price target increase from several analysts, with average price targets now around $77.56, indicating a generally positive outlook.

BW Gestao de Investimentos Ltda. decreased its position in CVS Health Corporation (NYSE:CVS - Free Report) by 16.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 150,000 shares of the pharmacy operator's stock after selling 30,000 shares during the quarter. BW Gestao de Investimentos Ltda.'s holdings in CVS Health were worth $10,162,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in CVS Health by 0.8% during the first quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock valued at $8,017,223,000 after buying an additional 969,027 shares during the period. Dodge & Cox grew its position in shares of CVS Health by 4.8% during the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator's stock valued at $4,976,856,000 after acquiring an additional 3,353,223 shares during the period. Invesco Ltd. increased its stake in shares of CVS Health by 13.2% in the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock worth $1,383,039,000 after purchasing an additional 2,375,764 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in CVS Health by 14.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator's stock worth $1,037,205,000 after purchasing an additional 1,942,886 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in CVS Health by 5.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock valued at $924,643,000 after purchasing an additional 728,924 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

NYSE:CVS traded up $0.07 during trading hours on Friday, reaching $73.76. The stock had a trading volume of 5,074,859 shares, compared to its average volume of 5,804,935. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The stock has a market capitalization of $93.56 billion, a PE ratio of 20.60, a PEG ratio of 0.81 and a beta of 0.62. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $74.53. The company has a 50 day moving average price of $66.60 and a two-hundred day moving average price of $66.00.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.6%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio is presently 74.30%.

Wall Street Analyst Weigh In

Several research firms have recently commented on CVS. Morgan Stanley raised their price objective on CVS Health from $80.00 to $82.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. Sanford C. Bernstein raised their target price on shares of CVS Health from $72.00 to $77.00 and gave the stock a "market perform" rating in a research note on Friday. Baird R W raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Truist Financial raised their price objective on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Finally, UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $67.00 to $79.00 in a report on Monday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $77.89.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.